Subclinical Cardiovascular Disease in US Adults With and Without Diabetes

Subclinical Cardiovascular Disease in US Adults With and Without Diabetes

Background We characterized the burden and prognostic value of subclinical cardiovascular disease (CVD) assessed by cardiac biomarkers among adults with and without diabetes in the general US population. Methods and Results We measured hs‐cTnT (high‐sensitivity cardiac troponin T) and NT‐proBNP (N‐t...

Full description

Bibliographic Details
Main Authors:	Michael Fang, Dan Wang, Olive Tang, John William McEvoy, Justin B. Echouffo‐Tcheugui, Robert H. Christenson, Elizabeth Selvin
Format:	Article
Language:	English
Published:	Wiley 2023-06-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	cardiac troponin diabetes NT‐proBNP population‐based study screening
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.029083

Similar Items

Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle‐Aged Adults
by: Stephen P. Juraschek, et al.
Published: (2018-05-01)

Cardiac effects of positive pressure ventilation in ARDS assessed by NT-proBNP, Troponin T and Troponin I
by: Yasser Sadek Nassar, et al.
Published: (2013-01-01)

Transthoracic echocardiography and cardiac biomarkers in healthy captive male and female squirrel monkeys (Saimiri spp.)
by: Laurent Locquet, et al.
Published: (2020-06-01)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
by: Zhu Q, et al.
Published: (2016-02-01)

Cardiovascular abnormalities in dogs with acute pancreatitis
by: Harry Cridge, et al.
Published: (2023-01-01)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
by: Stefanie Hendricks, et al.
Published: (2022-10-01)

Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01)

Brain–Heart Axis and Biomarkers of Cardiac Damage and Dysfunction after Stroke: A Systematic Review and Meta-Analysis
by: Chengyang Xu, et al.
Published: (2020-03-01)

Cardiac Biomarkers in Patients with Acute Pulmonary Embolism
by: Luc Janisset, et al.
Published: (2022-04-01)

Using N-terminal pro-B-type natriuretic peptide to diagnose cardiac abnormalities in children with dyspneaen with dyspnea
by: Zakaria Mukalla, et al.
Published: (2017-06-01)

Inverted Takotsubo Syndrome With HELLP Syndrome: A Case Report
by: Paul Gabarre, et al.
Published: (2022-03-01)

Device-measured movement behaviors and cardiac biomarkers in older adults without major cardiovascular disease: the Seniors-ENRICA-2 study
by: Blanca Fabre-Estremera, et al.
Published: (2023-03-01)

B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer?
by: Renato de Falco, et al.
Published: (2021-06-01)

Clinical roles of soluble ST2 for the outcomes of cardiac valve operations
by: Robert Chen
Published: (2016-04-01)

Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
by: Lena Hinrichs, et al.
Published: (2020-05-01)

Cardiac Troponin I but Not N-Terminal Pro-B-Type Natriuretic Peptide Predicts Outcomes in Cardiogenic Shock
by: Tobias Schupp, et al.
Published: (2023-08-01)

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01)

N-TerminalPro-B-TypeNatriuretic Peptide For Detecting Early Cardiac Dysfunction in Patients with Thyroid Dysfunction
by: Makbule Ulusoy, et al.
Published: (2013-09-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
by: Elena Palà, et al.
Published: (2019-11-01)

Cardiac dysfunction evoked by ECG and echocardiography changes and release of cardiac biomarkers in patients with aneurysmal subarachnoid haemorrhage.
by: Raluca Ungureanu, et al.
Published: (2019-12-01)

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
by: Clotilde Roy, et al.
Published: (2020-10-01)

Serum Pro‐N‐Cadherin Is a Marker of Subclinical Heart Failure in the General Population
by: Paul Durham Ferrell, et al.
Published: (2023-03-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

A Differential Profile of Biomarkers between Patients with Atrial Fibrillation and Healthy Controls
by: Ana Merino-Merino, et al.
Published: (2022-08-01)

N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
by: Gottsauner-Wolf Michael, et al.
Published: (2011-04-01)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
by: Demóstenes G.L. Ribeiro, et al.
Published: (2014-06-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)

Assessment of the Relationship between Periodontitis and Cardiac Parameters in Patients with Early Chronic Heart Failure: A Cross-Sectional Study
by: Antina Schulze, et al.
Published: (2024-03-01)

ECG and Biomarker Profile in Patients with Acute Heart Failure: A Pilot Study
by: Adriana Chetran, et al.
Published: (2022-12-01)

Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka
by: Jayasinghe Arachchige Nirosha Sandamali, et al.
Published: (2023-03-01)

Effect of type of diet on blood and plasma taurine concentrations, cardiac biomarkers, and echocardiograms in 4 dog breeds
by: Darcy Adin, et al.
Published: (2021-03-01)

Normalized Cardiac Structure and Function in COVID-19 Survivors Late After Recovery
by: Yi-Ping Gao, et al.
Published: (2021-11-01)

Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease
by: Jenny Wilshaw, et al.
Published: (2021-03-01)

Elevated N‐terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri‐urban township
by: Tess E. Peterson, et al.
Published: (2020-10-01)

Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015-12-01)

Serial echocardiographic evaluation of COVID-19 patients without prior history of structural heart disease: a 1-year follow-up CRACoV-HHS study
by: Agnieszka Olszanecka, et al.
Published: (2023-09-01)

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
by: Sonja Levy, et al.
Published: (2022-05-01)

Correlation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) with radiographic features of congestion in chest CT scan of patients with COVID-19
by: Naghmeh Ziaie, et al.
Published: (2023-07-01)

Changes in Cardiac Levels of Caspase-8, Bcl-2 and NT-proBNP Following 4 Weeks of Aerobic Exercise in Diabetic Rats
by: Saeid Tanoorsaz, et al.
Published: (2017-12-01)